Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/43199Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Devlin, Hannah | - |
| dc.date.accessioned | 2021-11-03T03:51:07Z | - |
| dc.date.available | 2021-11-03T03:51:07Z | - |
| dc.date.issued | 2021-11-03 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/43199 | - |
| dc.description | page 43 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | The Guardian Australia | en_US |
| dc.subject | Vaccination | en_US |
| dc.subject | Immune system | en_US |
| dc.title | Flu, cancer, HIV: after Covid success, what next for mRNA vaccines? | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Newspaper Clippings | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| November 3, 2021 pg 43.pdf | Flu, cancer, HIV: after Covid success, what next for mRNA vaccines? | 154.75 kB | Adobe PDF | View/Open |
Items in QC LIBROS are protected by copyright, with all rights reserved, unless otherwise indicated.